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ABSTRACT
In recent years, high pathogenicity avian influenza (HPAI) virus, H5N1, low pathogenicity avian influenza 
(LPAI) virus, H9N2, and both HPAI and LPAI H7 viruses have proved devastating for the affected econo-
mies reliant on poultry industry, and have posed serious public health concerns. These viruses have repeatedly 
caused zoonotic disease in humans, raising concerns of a potential influenza pandemic. Despite the focus on 
the HPAI H5N1 outbreak in 1997 some H7 strains have also shown to be occasionally adaptable to infecting 
humans. Therefore, applying knowledge of the H5 virus evolution and spread to the development of sensitive 
serological methods is likely to improve our ability to understand and respond to the emergence of other HPAI 
and LPAI viruses, present within the avian populations, with the potential to infect humans and other species. 
In the present study we describe the construction and production of lentiviral pseudotypes bearing envelope 
glycoproteins of LPAI and HPAI H7 avian influenza viruses, which have been responsible for several outbreaks 
in the past decade. The H7 pseudotypes were evaluated in pseudotype-based neutralization (pp-NT) assays in 
order to detect and quantify the presence of neutralizing antibodies in avian sera, which were confirmed H7 
positive by inhibition of haemagglutination (HI) test. Overall, our results substantiate influenza virus pseudo-
type neutralization as a robust tool for influenza sero-surveillance.
KEYWORDS: HPAI, H7 lentiviral pseudotype, LPAI, micro-neutralization, pandemic potential
INTRODUCTION
Influenza A viruses that primarily cause devastating infec-
tious disease in poultry, termed high pathogenicity avian 
influenza (HPAI), belong exclusively to the H5 and H7 
subtypes, although not all viruses of these subtypes cause 
HPAI. Due to the ability of certain subtypes to mutate into 
a high pathogenicity form and the consequent increased 
mammalian transmissibility and pandemic potential (Van 
Kerkhove et al, 2012), several studies have also shown the 
alarming effects of uncontrolled long-term circulation of H7 
low pathogenicity avian influenza (LPAI) viruses in  poultry 
(Capua and Marangon, 2006). In fact, the hypothesis that 
these viruses can be maintained in poultry populations 
and mutate to HPAI forms with public health repercus-
sions underlines the need for monitoring systems and active 
surveillance (Capua et al, 2000, Belser et al, 2009). Our 
understanding of human infections caused by avian influ-
enza viruses arise from numerous sources including sero- 
epidemiological studies, reports of human disease, relevant 
animal models and in vitro studies (Horimoto and Kawaoka, 
2001, de Wit et al, 2008, Peiris, 2009). Despite the public 
health attention since the emergence of Asian lineage H5N1 
HPAI virus outbreak in Hong Kong in 1997 and to the pre-
sent day, some H7 strains have also been shown to be very 
adaptable for widespread infection as confirmed by several 
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LPAI and HPAI H7 outbreaks that have occurred worldwide 
in poultry, occasionally resulting in their direct transmission 
to humans. The current H7N3 HPAI outbreak in Jalisco, 
 Mexico, demonstrates the continuing risk from the circula-
tion of certain subtypes (Centers for Disease Control and 
Prevention, 2012). Therefore, the pandemic potential of 
subtype H7 viruses should not be underestimated. Hence, 
stressing the need for new diagnostic approaches and 
technologies, genetic and antigenic data should be paired 
for integrated “surveillance” and serological studies, spe-
cifically focusing on the development of readily applicable 
assays for routine testing of LPAI and HPAI viruses and 
newly emerged variants (Cattoli and Terregino, 2008).
To date, a comprehensive panel of influenza pseudotypes 
bearing HA glycoproteins belonging to several subtypes, 
clades and subclades have been developed and optimized 
(Temperton et al, 2007, Wang et al, 2008, Corti et al, 2011). 
This panel however comprises only a few H7 influenza 
viruses that have been pseudotyped for serological pur-
poses, and therefore this study aims to show the feasibil-
ity of producing additional functional HPAI and LPAI H7 
influenza pseudotypes. For this purpose, H7 pseudotypes 
have been produced and tested against a panel of avian sera 
in pseudotype-neutralization assays (pp-NT) in order to 
provide a tool that will offer new perspectives in avian and 
human influenza diagnosis, as well as renewed confirmation 
of their potential use for comparative serology.
MATERIALS AND METHODS
Envelope glycoprotein cloning and plasmids
cDNA for HPAI H7N3 A/chicken/Pakistan/34668/1995 
(GenBank: CY035831), A/chicken/Netherlands/1/2003 
(GenBank: AY338458) and LPAI H7N1 A/chicken/
Italy/1082/1999 (GenBank: CY022677) was kindly pro-
vided by FAO, OIE and National Reference Laboratory 
for Newcastle Disease and Avian Influenza, Istituto Zoo-
profilattico Sperimentale delle Venezie. The H7 A/chicken/
FPV/Rostock/34 was kindly provided by FL Cossett 
(Human Virology Department, Lyon). The HPAI A/chicken/
Italy/13474/99 HA (GenBank: AJ491720) and NA were 
kindly provided by the FLUPAN partner laboratories.
The HA of FPV/Rostock/34 (GenBank: AAA43150) was 
cloned into phCMV vector, while the HAs of HPAI H7 A/
chicken/Italy/13474/99, A/chicken/Pakistan/34668/1995, 
LPAI H7 A/chicken/Italy/1082/1999 and A/chicken/
Italy/13474/99 were cloned into pI.18, a pUC-based plasmid 
as described previously (Temperton et al, 2007, Wright et al, 
2008). The NAs of A/chicken/Pakistan/34668/1995 (N3) 
(GenBank: CY035833), A/chicken/Netherlands/1/2003 
(N7) (GenBank: AY340077) and N1 from A/chicken/
Italy/13474/99 were also cloned into pI.18.
Serum samples
All the sera tested were provided by FAO, OIE and National 
Reference Laboratory for Newcastle Disease and Avian 
influenza, Istituto Zooprofilattico delle Venezie and com-
prised seven avian sera positive for antibodies to the H7N1 
vaccine strain (A/chicken/Italy/1067/99 LPAI) with titres 
ranging from low (1:32) to high (1:2048) when tested by 
HI (HI reference antigen: H7N1 A/Starling/Africa/985/79) 
according to standard protocols indicated by European 
Medicine Agency and ten sera positive for H7 collected 
from turkeys during an Italian outbreak of AI caused by 
an LPAI virus H7N3 (A/turkey/Italy/9289/V02), that were 
previously tested by HI (Decision2006/437/CE, 2006). Ten 
negative sera confirmed by Agar Gel Immunodiffusion 
assay (AGID) and Indirect Enzyme-linked immunosorbent 
assay (ELISA) (BioCheck Avian Influenza Antibody Test 
Kit, BioCheck UK Ltd.) were used and 2 subtyping poly-
clonal hyperimmune chicken antisera were used for testing 
subtype specificity (H7N1 and H7N3). The antisera were 
produced in specific pathogen-free chickens by inoculation 
with viruses (inactivated by beta-propriolactone if HPAI 
viruses) as described previously (Terregino et al, 2010). A 
panel of H5 positive sera that were collected from chickens 
vaccinated with an inactivated adjuvanted H5N2 vaccine 
has been included in the study.
Influenza H7 pseudotype production
A panel of lentiviral pseudotypes expressing HAs from 
HPAI H7N1 A/chicken/Italy/13474/99, H7N3 A/chicken/
Pakistan/34668/1995, H7 A/chicken/FPV/Rostock/34, LPAI 
H7N1 A/chicken/1082/1999 viruses were generated essen-
tially as described previously (Temperton et al, 2007, Corti 
et al, 2010, Corti et al, 2011). In order to produce HA and NA 
A/chicken/Italy/13474/99 influenza pseudotypes with differ-
ent NAs (N1, N3 and N7), the neuraminidase activity was pro-
vided by NA plasmid co-transfection (N1 from H7 A/chicken/
Italy/13474/99, N3 from H7 A/chicken/Pakistan/34668/1995 
and N7 from H7 A/chicken/Netherlands/1/2003) in lieu of 
exogenous bacterial NA addition (HA: NA transfection ratio 
of 3:1) (Temperton et al, 2007). For the production of the 
LPAI H7 A/chicken/1082/1999 pseudotype, a TMPRSS2 
protease expressing plasmid was additionally added to the 
transfection mixture (in order to mediate the cleavage in the 
LPAI H7 pseudotypes) (Wang et al, 2008). For transfection, 
1 × 104 cells/well were plated 24 hr prior to the addition of a 
complex comprising plasmid DNA and FuGENE-6 transfec-
tion reagent (Roche, UK). 
The HIV- type 1 (HIV-1) gag-pol construct (pCMV-'8.91) 
and the reporter plasmid (pCSFLW, expressing firefly lucif-
erase) were transfected concurrently with the required 
envelope glycoprotein constructs at a ratio of 1:1:1.5 ratio 
(p8.91:pI.18-HA:pCSFLW).
In parallel, a non-envelope glycoprotein control pseudotype 
was generated by co-transfection of producer cell lines with 
two plasmids, gag-pol pCMV-'8.91 and pCSFLW. Super-
natants were harvested 48 hr and 72 hr post-transfection and 
titrated onto HEK 293T/17 cell line.
Pp-NT neutralization assays
For the HPAI H7 A/chicken/Italy/13474/99, A/chicken/
FPV/Rostock/34 and LPAI H7 A/chicken/Italy/1082/1999 
neutralization assays, two-fold serial dilutions of each 
serum sample were mixed with pseudotyped viruses 
(resulting in 1 × 106 firefly relative light units, RLUs) 
at a 1:1, v/v, ratio. After incubation at 37°C for 1 hr, 
1 × 104 HEK 293/17 cells were added to each well of a 
white 96-well-flat- bottomed tissue culture plate. For H7 
A/chicken/Italy/13474/99 pseudotypes, neutralization 
assays were also undertaken for screening 10 H7 positive 
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sera  collected from naturally infected turkeys and for a 
panel of 10 H5 positive chicken sera (previously tested 
by HI). RLUs were evaluated after 48 hr by luminometry 
using the Bright-Glo assay system (Promega, UK). To 
measure the neutralization activity of this panel of sera, 
the 90% inhibitory concentration (IC
90
) was determined 
as the serum dilution resulting in a 90% reduction of a 
single round of infection (reporter gene-mediated signal). 
Values are expressed as a percentage when compared with 
the signal from the cell only control (equivalent to 100% 
 neutralization and/or no infection) and the signal from 
a virus only control equivalent to 0% neutralization or 
100% infection.
Statistical analysis
The estimation of pseudotype transduction titers (Figure 1 
and Figure 2) has been perfomed using ExcelTM software 
where pseudotype titers obtained at each of a range of dilu-
tion points were expressed as RLU/ml and the arithmetic 
mean was calculated by GrapdPad Prism (version 5, Graph-
Pad Software, San Diego, CA, USA). Statistical analyses 
were also undertaken for the analysis of pp-NT assays using 
GraphPad. Pp-NT titers were normalized and IC
90
  values 
were calculated by a non-linear regression model (log 
(inhibitor) vs normalized response-variable slope) analysis 
(Table 1). 
RESULTS
Production of lentiviral HPAI and LPAI H7 pseudotype 
particles (H7pp)
Pseudotypes expressing HAs from four H7 viruses 
(HPAI A/chicken/Italy/13474/1999, A/chicken/FPV/Ros-
tock/34, A/chicken/Pakistan/34668/1995 and LPAI H7 A/
chicken/1082/1999) were generated (Figure 1). Addition-
ally, pseudotypes bearing both HA and NA glycoproteins of 
H7N1 A/chicken/Italy/13474/99 were generated ( Figure 1). 
We evaluated the transduction efficiency of each H7 pseu-
dotype by measuring the titers expressed as RLU/ml in 
HEK293/17 cells. For all the transduction measurements 
two controls were included: a non-envelope glycoprotein 
control and a cell only control.
As expected, the RLU values for the non-envelope con-
trol (pCMV-'8.91 and the reporter pCSFLW plasmids) 
were similar to mock transduction. In contrast, signifi-
cantly higher RLU values, compared to the controls, were 
detected in cells transduced with HPAI H7 A/chicken/
Italy/13474/99, A/chicken/FPV/Rostock/34, A/chicken/
Pakistan/34668/1995 and LPAI H7 A/chicken/1082/1999 
pseudotypes. Interestingly, in cells transduced by H7N1 A/
chicken/Italy/13474/99 pseudotypes (where the NA activ-
ity was provided by the cognate plasmid) the RLU values 
were two log
10
s higher than the same H7 HA pseudotype 
produced by exogenous NA treatment.
Subsequently, a set of three HPAI H7 A/chicken/
Italy/13474/99 HA+NA pseudotypes with NAs  belonging 
to different H7 avian influenza strains (N1, N3, N7) 
Figure 1. Infectivity of pseudotyped lentiviral vectors  carrying 
HA glycoprotein of HPAI A/chicken/Italy/13474/1999, A/
chicken/Pakistan/34668/1995, H7 A/chicken/FPV/Rostock/34 
and LPAI H7N1 A/chicken/1082/1999. Influenza pseudotypes 
were produced by adding exogenous neuraminidase 24 hr after 
transfection (for H7 A/chicken/Italy/13474/1999, additionally 
an NA plasmid has been used). The transduction titers of the 
released pseudotypes were expressed as the mean ±SD of relative 
luciferase units (RLUs).
Figure 2. Panel of H7 A/chicken/Italy/13474/1999 HA 
 pseudotypes produced in combination with different NA  plasmids 
(N1 from A/chicken/Italy/13474/1999, N3 from A/chicken/ 
Pakistan/34668/1995 and N7 from A/chicken/ Netherlands/1/2003). 
Comparison of transduction efficiency in target HEK 293T cells. 
Titers of released pseudotypes were expressed as the mean ±SD 
of relative luciferase units (RLUs).
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Table 1. Comparison of neutralization activity of chicken immune sera (positive for the H7N1 vaccine strain: A/chicken/Italy/1067/1999) against three different H7 pseudotypes: A/ck/Italy/1082/1999, 
A/ck/Italy/13474/1999 and A/chicken/FPV/Rostock/34 (Set A). H7 Influenza pseudotypes bearing HA from A/ck/Italy/13474/1999 were also used for testing neutralizing activity of a panel of sera 
(Set B: No. 8–No. 17) collected from naturally infected turkeys (positive for H7N3 A/turkey/Italy/9289/V02). Additional sera previously found H5 positive by HI have been tested (Set C). A non-linear 
regression approach, dose-response inhibition has been used for the analysis). Values are reported as 90% inhibitory concentration (IC
90
). Haemagglutination inhibition titres are also reported.
(A) H7 positive sera (vaccinated with an LPAI H7N1 vaccine)
(B) H7 positive sera ( H7N3 positive, naturally 
infected)
(C) H5 positive sera (vaccinated with an 
LPAI H5N2 vaccine)
Serum No.
IC90 vs H7N1 A/
chicken/1082/ 
1999 (LPAI)
IC90 vs H7N1 A/
chicken/13474/ 
1999 (HPAI)
IC90 vs A/FPV/
Rostock/34
HI titres
A/ck/Italy/ 
1067/99H7N1
Serum 
No.
IC90 vs H7N1 A/
chicken/13474/ 
1999 (HPAI)
HI titres
A/ty/Italy/9289/
V02 H7N3
Serum 
No.
IC90 vs H7N1 A/
chicken/13474/ 
1999 (HPAI)
HI titres
A/ty/Italy/ 
80H5N2
1 (6612-36) >5120 >5120 >5120 1:2048 8 >5120 1:2048 3929-1 40 1:2048
2 (6612-42) >5120 >5120 >5120 1:1024 9 >5120 1:1024 3929-9 40-80 1:1024
3 (6612-45) >5120 >5120 >5120 1:512 10 2560-5120 1:512 3929-6 <40 1:512
4 (188-2) 1280-2560 320-640 640-1280 1:256 11 160-320 1:256 3930-19 <40 1:256
5 (188-1) 1280-2560 640-1280 640-1280 1:128 12 640-1280 1:128 3930-20 <40 1:128
6 (10-3) 2560-5120 320-640 320-640 1:64 13 160-320 1:64 3933-44 <40 1:64
7 (10-4) 1280-2560 160-320 160-320 1:32 14 80-160 1:32 3933-41 <40 1:32
H7N1 +ve 27782 >5120 >5120 n/d 15 <40 1:16 3933-50 <40 1:16
H7N3 +ve >5120 >5120 640-1280 n/d
16 40-80 1:8 3933-41 <40 1:8
17 <40 1:4 3933-44 <40 1:4
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employ them as tools in serological assays in parallel with 
the classical serological method HI.
A panel of functional HPAI H7 pseudotypes was pro-
duced in addition to a LPAI H7 pseudotype, overcoming 
the difficulties in cleaving the precursor HA from a strain 
that lacks the polybasic cleavage site (Wang et al, 2008). 
For all the H7 pseudotypes, high transduction titers were 
obtained as confirmed by RLU/ml values in Figure 1. How-
ever, the A/chicken/Pakistan/34668/1995 strain exhibited a 
lower transduction efficiency. This is possibly due to lower 
 glycoprotein expression or sub-optimal cleavage of the 
HA by cellular proteases (Nefkens et al, 2007, Wang et al, 
2008, Choi et al, 2009, Klenk and Garten, 1994). Produc-
tion of H7 pseudotypes bearing HA alone from A/chicken/
Italy/13474/99, or HA+NA by additional co-transfection of 
different NAs was attempted. The rationale for this is the 
observation that H7 subtype viruses with many different 
NA types have transmitted from birds to humans compared 
to the situation with the H5 subtype (Belser et al, 2009, 
Abdel-Ghafar et al, 2008). We show using our pseudotype 
production system that not all the HA and NA combina-
tions were equally effective at generating high-titer virus 
stocks (Figure 2). 
Lastly, three H7 pseudotypes were used for neutralization 
assays and results compared to the classical HI serological 
test. As expected, the pp-NT assay returned higher titers 
compared to HI and a significantly lower antibody response 
was detected against HPAI strains compared to the LPAI 
strain.
CONCLUSIONS 
 s  The development of pseudotype influenza viruses may 
provide excellent serological reagents for testing sera 
originating from birds but also from other species, 
including humans. 
 s  The flexible and safe use of pseudotype influenza virus 
in neutralization assays may prove useful for influenza 
control strategies enabling the evaluation of the levels 
of neutralizing immunity induced by field isolates and 
vaccines, and the possible mechanisms of cross-reactive 
immunity.
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was  generated and transduction efficiency was esti-
mated.  Surprisingly, low titers were obtained when the 
N7  plasmid (from H7 A/Netherlands/1/2003) was used 
compared to N3 and N1 plasmids for H7 A/chicken/
Italy/13474/99 pseudotype production (4 log
10
s higher 
when the N1  plasmid was used instead of the N7 plasmid) 
(Figure 2).
Development and evaluation of H7 pseudotype-based 
neutralization assay
To develop and evaluate the utility of H7 pseudotypes in 
pp-NT assays, neutralizing antibody responses were meas-
ured in sera obtained by vaccination of chickens with a 
H7N1 vaccine against three different H7 pseudotypes: HPAI 
H7 A/chicken/FPV/Rostock/34, A/chicken/Italy/13474/99 
and LPAI H7 A/chicken/1082/1999 strains. The same panel 
of sera was also found positive when tested by HI against 
H7N1 A/Starling/Africa/985/79. 
The results obtained using all the H7 pseudotypes when 
tested in duplicate displayed a clear and wide antibody 
response confirmed by high neutralization titers (titers 
between t1:320 and >1:5120) compared to the negative 
controls (data not shown). The neutralization titers for H7 
LPAI A/chicken/1082/1999 were slightly lower (Table 1A) 
compared to HPAI H7 A/chicken/FPV/Rostock/34 and 
A/chicken/Italy/13474/99 pseudotypes (Table 1B, 1C). 
Additional pp-NT assays have been undertaken to test H7 
A/chicken/Italy/13474/99 pseudotypes against sera from 
H7 positive turkeys (by natural infection) and H5 posi-
tive chickens (by vaccination) and results are shown in 
Table 1.
DISCUSSION
Within the last decade, poultry outbreaks caused by LPAI 
and HPAI viruses of the H7N1, H7N2, H7N3, H7N4 and 
H7N7 subtypes have resulted in the culling of millions of 
birds. Since 2002, this has resulted additionally in >100 
cases of human exposure in the Netherlands, Italy, Canada, 
the United States and United Kingdom (Capua and Maran-
gon, 2006, Belser et al, 2009). The presence of H7 LPAI 
viruses in many countries and the current H7N3 outbreak in 
Mexico demonstrates the constant risk posed by certain H7 
avian influenza subtypes to mutate from the low pathoge-
nicity to the high pathogenicity form. Despite the relatively 
limited human transmissibility of HPAI H7 viruses, they 
have been shown to share many properties and molecular 
features with the HPAI H5 subtype. Primarily, the presence 
of a polybasic cleavage site within the HA sequence leads 
to the recognition by ubiquitous proteases and subsequent 
systemic spread of the virus resulting in death of infected 
birds. Additionally, the marked increase in the number of 
LPAI outbreaks highlights the importance of carrying out an 
active sero-surveillance for this subtype in order to monitor 
the evolution of these strains have the potential to impact 
on human and animal health (Capua and Alexander, 2007).
With a serological perspective, this study aimed to develop 
a panel of H7 HPAI and LPAI influenza pseudotypes from 
strains that were responsible for severe outbreaks, and to 
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